SK bioscience financial statements

SK바이오사이언스KRX:302440 · KOSPI · Healthcare · sector #23
₩38,000+2.01%
2026-10-07 close

SK bioscience's published financial data is dated 2026-10-04. 2024 revenue was KRW 267.55B. 2024 operating profit was −KRW 123.02B.

Reported results

SK bioscience notifications

Quantus Signal · live data · not investment advice · Privacy Policy